Swaak, A.J., Moutsopoulos, H.M., Dratwianka, B., Kalden, J.R., Tosi, S., Marchesoni, A., ...
OBJECTIVE: Patients characterized with antinuclear antibodies (ANA) and disease symptoms related to one organ system can be described as having incomplete systemic lupus erythematosus (SLE). The aim...
Swaak, A.J., Rozman, B., Chwalinska-Sadowska, H, Bombardieri, S., Kovacs, A., Schneider, M., ...
OBJECTIVE: Most information available about the disease course of patients with systemic lupus erythematosus (SLE) is restricted to the first 5 yr after disease onset. Data about the disease course...
Manger, K, Manger, B, Repp, R, Geisselbrecht, M, Geiger, A, Pfahlberg, A, ...
Background: The survival rate in patients with systemic lupus erythematosus (SLE) has improved dramatically during the past four decades to 96.6% (five year) in the Erlangen cohort, but it is nearly...
Manger, K, Repp, R, Jansen, M, Geisselbrecht, M, Wassmuth, R, Westerdaal, N, ...
Background: Receptors for IgG play an important part in immune complex clearance. Several studies have identified polymorphisms of receptors for the Fc fragment of IgG (FcγR) as genetic factors...
Factors associated with coronary artery calcification in young female patients with SLE
Manger, K, Kusus, M, Forster, C, Ropers, D, Daniel, W, Kalden, J, ...
Background: With improved survival rates of patients with systemic lupus erythematosus (SLE), damage such as accelerated atherosclerosis gains increasing importance.